SCHEMBL11273462

SCHEMBL11273462

CN(CCOc1ccccc1)CC(O)COc1ccc(O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ MEN1 O00255 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ ESRRB O95718 3/20 0.48
▸ ESR1 P03372 4/20 0.48
▸ POLB P06746 1/20 0.47
▸ HIF1A Q16665 2/20 0.47
▸ LTA4H P09960 1/20 0.47
▸ ESR2 Q92731 3/20 0.46
▸ KDM1A O60341 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ PLD2 O14939 1/20 0.46
▸ PGR P06401 1/20 0.46
▸ ESRRG P62508 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11276906 0.90 CHRNB2 (0.57) LMNAKDM4EMAPK1MEN1KMT2A
SCHEMBL11438620 0.88 CHRNB2 (0.58) LMNAKDM4EMAPK1MEN1KMT2A
SCHEMBL11275931 0.88 TSHR (0.53) LMNAKDM4EMAPK1MEN1KMT2A
SCHEMBL12212607 0.81 KDM4E (0.59) LMNAKDM4EMAPK1MEN1KMT2A
SCHEMBL10346703 0.81 ALDH1A1 (0.63) LMNAMAPK1ESR1POLBHIF1A
SCHEMBL10838063 0.80 HIF1A (0.51) LMNAKDM4EMAPK1MEN1KMT2A
SCHEMBL15296872 0.79 POLB (0.53) LMNAKDM4EMAPK1MEN1KMT2A
SCHEMBL10836817 0.78 LMNA (0.49) LMNAKDM4EMAPK1MEN1KMT2A
SCHEMBL6264190 0.76 HIF1A (0.57) LMNAKDM4EPOLBHIF1AALDH1A1
SCHEMBL23074660 0.76 KCNH2 (0.54) LMNAKDM4EMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0064487-A1 New substituted 3-(parasubstituted)phenoxy-1-alkylamino-propanol-2-s, as well as process for their preparation, pharmaceutical preparations containing same, and method for treating cardiac failure Aktiebolaget Hässle (SE) 1982-11-10 — — EP disclosed
Send feedback